Wednesday, December 10, 2025 10:18:02 PM
I agree with those who think the BLA submission to the FDA could happen before the end of this year. That news alone could take the share price to around $40.
But what will happen in 2026?
There should be 5 big 2026 catalysts...
1. Deramiocel FDA approval
2. Deramiocel European + ROW partnership
3. StealthX vaccine results
4. StealthX BP and NIAID partnership(s)
5. Deramiocel US earnings in 2026
Capricor is already CASH RICH and another $80 million will come with approval as will a PRV which recently have been sold for over $150 million.
Good partnerships could bring the share price up to the $200 range IMO. But it could be bought out for much more at any time.
But what will happen in 2026?
There should be 5 big 2026 catalysts...
1. Deramiocel FDA approval
2. Deramiocel European + ROW partnership
3. StealthX vaccine results
4. StealthX BP and NIAID partnership(s)
5. Deramiocel US earnings in 2026
Capricor is already CASH RICH and another $80 million will come with approval as will a PRV which recently have been sold for over $150 million.
Good partnerships could bring the share price up to the $200 range IMO. But it could be bought out for much more at any time.
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent CAPR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2026 01:55:07 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2026 01:52:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:15:07 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/19/2026 06:41:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 03:40:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:00:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 09:20:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:06:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:40:53 PM
- Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 • GlobeNewswire Inc. • 05/04/2026 08:05:00 PM
- Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting • GlobeNewswire Inc. • 04/22/2026 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:31:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 08:24:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 12:00:11 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/31/2026 09:24:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:23:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:23:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 11:15:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 09:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:01:07 PM
